Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 288 participants.

Also called NCT01851759

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 288 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01851759
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01851759. Randomized; double masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2014-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction
Intervention (Drug)
cinepazide
Intervention (Drug)
placebo
Lead sponsor
Xijing Hospital (class: other)

Record details

Record id
cardio:ct-nct01851759
Content hash
33cb1a33f15b81cdb5ad58a1f14481101266ccbbf73564484241968a01520ef6